Protein Science, Vol 7, Issue 3 637-648, Copyright © 1998 by Cold Spring Harbor Laboratory Press

ARTICLE

Role of the amino-terminal region of streptokinase in the generation of a fully functional plasminogen activator complex probed with synthetic peptides

D. NIHALANI, R. KUMAR, K. RAJAGOPAL and G. SAHNI
Institute of Microbial Technology, Sector 39-A, Chandigarh 160036, India

The mechanism whereby fragments of streptokinase (SK) derived from its N terminus (e.g., SK1-59 or SK1-63) enhance the low plasminogen (PG)-activating ability of other fragments, namely SK64-386, SK60-414, SK60-387, and SK60-333 (reported previously), has been investigated using a synthetic peptide approach. The addition of either natural SK1-59, or chemically synthesized SK16-59, at saturation (about 500-fold molar excess) generated amidolytic and PG activation capabilities in equimolar mixtures of human plasminogen (HPG) and its complementary fragment (either SK60-414 or SK56-414, prepared by expression of truncated SK gene fragments in Escherichia coli) that were approximately 1.2- and 2.5-fold, respectively, of that generated by equimolar mixtures of native SK and HPG. Although in the absence of SK1-59 equimolar mixtures of SK56-414 and HPG could generate almost 80% of amidolytic activity, albeit slowly, less than 2% level of PG activation could be observed under the same conditions, indicating that the contribution of the N-terminal region lay mainly in imparting in SK56-414 an enhanced ability for PG activation. The ability of various synthetic peptides derived from the amino-terminal region (SK16-51, SK16-45, SK37-59, SK1-36, SK16-36, and SK37-51) to (1) complement equimolar mixtures of SK56-414 and HPG for the generation of amidolytic and PG activation functions, (2) inhibit the potentiation of SK56-414 and HPG by SK16-59, and (3) directly inhibit PG activation by the 1:1 SK-HPG activator complex was tested. Apart from SK16-59, SK16-51, and 16-45, the ability to rapidly generate amidolytic potential in HPG in the presence of SK56-414 survived even in the smaller SK-peptides, viz., SK37-59 and SK37-51. However, this ability was abolished upon specifically mutating the sequence -LTSRP-, present at position 42-46 in native SK. Although SK16-51 retained virtually complete ability for potentiation of PG activation in comparison to SK16-59 or SK1-59, this ability was reduced by approximately fourfold in the case of SK16-45, and completely abolished upon further truncation of the C-terminal residues to SK16-36 or SK1-36. Remarkably, however, these peptides not only displayed ability to bind PG, but also showed strong inhibition of PG activation by the native activator complex in the micromolar range of concentration; the observed inhibition, however, could be competitively relieved by increasing the concentration of substrate PG in the reaction, suggesting that this region in SK contains a site directed specifically toward interaction with substrate PG. This conclusion was substantiated by the observation that the potentiation of PG activating ability was found to be considerably reduced in a peptide (SK25-59) in which the sequence corresponding to this putative locus (residues 16-36) was truncated at the middle. On the other hand, fragments SK37-51 and SK37-59 did not show any inhibition of the PG activation by native activator complex. Taken together, these findings strongly support a model of SK action wherein the HPG binding site resident in the region 37-51 helps in anchoring the N-terminal domain to the strong intermolecular complex formed between HPG and the region 60-414. In contrast, the site located between residues 16 and 36 is qualitatively more similar to the previously reported PG interacting site (SK254-273) present in the core region of SK, in being involved in the relatively low-affinity enzyme-substrate interactions of the activator complex with PG during the catalytic cycle.
CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				V. Sundram, J. S. Nanda, K. Rajagopal, J. Dhar, A. Chaudhary, and G. Sahni Domain Truncation Studies Reveal That the Streptokinase-Plasmin Activator Complex Utilizes Long Range Protein-Protein Interactions with Macromolecular Substrate to Maximize Catalytic Turnover J. Biol. Chem., August 15, 2003; 278(33): 30569 - 30577. [Abstract] [Full Text] [PDF]

				L. V. Mundada, M. Prorok, M. E. DeFord, M. Figuera, F. J. Castellino, and W. P. Fay Structure-Function Analysis of the Streptokinase Amino Terminus (Residues 1-59) J. Biol. Chem., June 27, 2003; 278(27): 24421 - 24427. [Abstract] [Full Text] [PDF]

				N. Wakeham, S. Terzyan, P. Zhai, J.A. Loy, J. Tang, and X.C. Zhang Effects of deletion of streptokinase residues 48-59 on plasminogen activation Protein Eng. Des. Sel., September 1, 2002; 15(9): 753 - 761. [Abstract] [Full Text] [PDF]

				I. P. Gladysheva, I. Y. Sazonova, S. A. Chowdhry, L. Liu, R. B. Turner, and G. L. Reed Chimerism Reveals a Role for the Streptokinase beta -Domain in Nonproteolytic Active Site Formation, Substrate, and Inhibitor Interactions J. Biol. Chem., July 19, 2002; 277(30): 26846 - 26851. [Abstract] [Full Text] [PDF]

				J. Dhar, A. H. Pande, V. Sundram, J. S. Nanda, S. C. Mande, and G. Sahni Involvement of a Nine-residue Loop of Streptokinase in the Generation of Macromolecular Substrate Specificity by the Activator Complex through Interaction with Substrate Kringle Domains J. Biol. Chem., April 5, 2002; 277(15): 13257 - 13267. [Abstract] [Full Text] [PDF]

				X. Wang, X. Lin, J. A. Loy, J. Tang, and X. C. Zhang Crystal Structure of the Catalytic Domain of Human Plasmin Complexed with Streptokinase Science, September 11, 1998; 281(5383): 1662 - 1665. [Abstract] [Full Text]

				L. Liu, I. Y. Sazonova, R. B. Turner, S. A. Chowdhry, J. Tsai, A. K. Houng, and G. L. Reed Leucine 42 in the Fibronectin Motif of Streptokinase Plays a Critical Role in Fibrin-independent Plasminogen Activation J. Biol. Chem., November 22, 2000; 275(48): 37686 - 37691. [Abstract] [Full Text] [PDF]